Shen S, Teysir J, Safonov A, Bromberg M, et al. Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancer. Breast Cancer Res 2026 Jan 31. doi: 10.1186/s13058-025-02152.
PMID: 41620612